{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:48:40Z","timestamp":1785037720881,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,8]]},"DOI":"10.7759\/cureus.15516","type":"journal-article","created":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T12:13:50Z","timestamp":1623154430000},"source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Accuracy of MRI in Evaluating Response After Neoadjuvant Systemic Therapy in Operable Breast Cancer"],"prefix":"10.7759","author":[{"given":"Abdullah R","family":"Khazindar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Abdulmonem L","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atlal","family":"Abusanad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa I","family":"Bakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alya","family":"Bin Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed T","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/1745505716677139","article-title":"Neoadjuvant chemotherapy in breast cancers","volume":"12","author":"Masood S","year":"2016","unstructured":"Masood S. Neoadjuvant chemotherapy in breast cancers. Womens Health (Lond). 2016, 12:480-91. 10.1177\/1745505716677139","journal-title":"Womens Health (Lond)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S253961","article-title":"Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer","volume":"14","author":"Wang H","year":"2020","unstructured":"Wang H, Mao X. Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer. Drug Des Devel Ther. 2020, 14:2423-33. 10.2147\/DDDT.S253961","journal-title":"Drug Des Devel Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4137\/BCBCR.S33163","article-title":"Relevance of pathological complete response after neoadjuvant therapy for breast cancer","volume":"10","author":"Pennisi A","year":"2016","unstructured":"Pennisi A, Kieber-Emmons T, Makhoul I, Hutchins L. Relevance of pathological complete response after neoadjuvant therapy for breast cancer. Breast Cancer (Auckl). 2016, 10:103-6. 10.4137\/BCBCR.S33163","journal-title":"Breast Cancer (Auckl)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S247279","article-title":"Prediction of pathologic complete response by ultrasonography and magnetic resonance imaging after neoadjuvant chemotherapy in patients with breast cancer","volume":"12","author":"Zhang K","year":"2020","unstructured":"Zhang K, Li J, Zhu Q, Chang C. Prediction of pathologic complete response by ultrasonography and magnetic resonance imaging after neoadjuvant chemotherapy in patients with breast cancer. Cancer Manag Res. 2020, 12:2603-12. 10.2147\/CMAR.S247279","journal-title":"Cancer Manag Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/qims.2019.11.16","article-title":"The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer","volume":"10","author":"Zhang X","year":"2020","unstructured":"Zhang X, Wang D, Liu Z, et al.. The diagnostic accuracy of magnetic resonance imaging in predicting pathologic complete response after neoadjuvant chemotherapy in patients with different molecular subtypes of breast cancer. Quant Imaging Med Surg. 2020, 10:197-210. 10.21037\/qims.2019.11.16","journal-title":"Quant Imaging Med Surg"},{"key":"ref6","article-title":"Part 1: simple definition and calculation of accuracy, sensitivity and specificity","volume":"3","author":"Baratloo A","year":"2015","unstructured":"Baratloo A, Hosseini M, Negida A, El Ashal G. Part 1: simple definition and calculation of accuracy, sensitivity and specificity. Emerg (Tehran). 2015, 3:48-9.","journal-title":"Emerg (Tehran)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017","volume":"119","author":"De Los Santos JF","year":"2013","unstructured":"De Los Santos JF, Cantor A, Amos KD, et al.. Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017. Cancer. 2013, 119:1776-83. 10.1002\/cncr.27995","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar P","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al.. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014, 384:164-72. 10.1016\/S0140-6736(13)62422-8","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2018.04.018","article-title":"MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis","volume":"40","author":"Li H","year":"2018","unstructured":"Li H, Yao L, Jin P, Hu L, Li X, Guo T, Yang K. MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast. 2018, 40:106-15. 10.1016\/j.breast.2018.04.018","journal-title":"Breast"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23470","article-title":"Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology","volume":"109","author":"Chen JH","year":"2014","unstructured":"Chen JH, Bahri S, Mehta RS, et al.. Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol. 2014, 109:158-67. 10.1002\/jso.23470","journal-title":"J Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-1800-x","article-title":"Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype","volume":"5","author":"Fukuda T","year":"2016","unstructured":"Fukuda T, Horii R, Gomi N, et al.. Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype. Springerplus. 2016, 5:152. 10.1186\/s40064-016-1800-x","journal-title":"Springerplus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-019-05032-9","article-title":"MRI performance in detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer","volume":"43","author":"Yu N","year":"2019","unstructured":"Yu N, Leung VWY, Meterissian S. MRI performance in detecting pCR after neoadjuvant chemotherapy by molecular subtype of breast cancer. World J Surg. 2019, 43:2254-61. 10.1007\/s00268-019-05032-9","journal-title":"World J Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.181.5.1811275","article-title":"Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy","volume":"181","author":"Rosen EL","year":"2003","unstructured":"Rosen EL, Blackwell KL, Baker JA, et al.. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol. 2003, 181:1275-82. 10.2214\/ajr.181.5.1811275","journal-title":"AJR Am J Roentgenol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-010-0235-4","article-title":"MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes","volume":"18","author":"Nakahara H","year":"2011","unstructured":"Nakahara H, Yasuda Y, Machida E, et al.. MR and US imaging for breast cancer patients who underwent conservation surgery after neoadjuvant chemotherapy: comparison of triple negative breast cancer and other intrinsic subtypes. Breast Cancer. 2011, 18:152-60. 10.1007\/s12282-010-0235-4","journal-title":"Breast Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-018-00934-3","article-title":"Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla","volume":"26","author":"Bi Z","year":"2019","unstructured":"Bi Z, Liu J, Chen P, et al.. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla. Breast Cancer. 2019, 26:373-7. 10.1007\/s12282-018-00934-3","journal-title":"Breast Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.remn.2013.03.006","article-title":"Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis","volume":"32","author":"Rebollo-Aguirre AC","year":"2013","unstructured":"Rebollo-Aguirre AC, Gallego-Peinado M, S\u00e1nchez-S\u00e1nchez R, Pastor-Pons E, Garc\u00eda-Garc\u00eda J, Chamorro-Santos CE, Menj\u00f3n-Beltr\u00e1n S. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with operable breast cancer and positive axillary nodes at initial diagnosis. Rev Esp Med Nucl Imagen Mol. 2013, 32:240-5. 10.1016\/j.remn.2013.03.006","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2018.21.e54","article-title":"Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer in diagnosis","volume":"21","author":"Choi HJ","year":"2018","unstructured":"Choi HJ, Kim I, Alsharif E, et al.. Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with axillary node-positive breast cancer in diagnosis. J Breast Cancer. 2018, 21:433-41. 10.4048\/jbc.2018.21.e54","journal-title":"J Breast Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/58002-diagnostic-accuracy-of-mri-in-evaluating-response-after-neoadjuvant-systemic-therapy-in-operable-breast-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:09Z","timestamp":1707507309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/58002-diagnostic-accuracy-of-mri-in-evaluating-response-after-neoadjuvant-systemic-therapy-in-operable-breast-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,8]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.15516","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,8]]}}}